June 11, 2018
On June 11, 2018, Salk’s Board of Trustees met to discuss the findings of the Institute’s investigation into allegations against Dr. Inder Verma. Our commitment from the outset has been to undertake an investigatory process that is thorough and impartial and to take action as appropriate. Although we will not comment on the details of this confidential personnel matter, we wanted to share with you the outcome of this process.
Based on the findings of the investigator, the Institute has considered appropriate responsive action. Last week, prior to the board concluding its discussions regarding the investigation and taking formal action, Dr. Verma tendered his unconditional resignation. This morning, the Board of Trustees voted unanimously to accept it.
As we have acknowledged, this has been a challenging time for the Institute. We have been heartened by the way the Salk community has come together and worked together to face these challenges.
When we signed on to be part of the Salk, we signed on to Jonas Salk’s bold mission to better humanity. And no humanistic value can be more important than respectful, fair treatment of each and every person – not just on our campus, but in all walks of our lives.
Sincerely,
Dan Lewis, Chair, Board of Trustees
Rusty Gage, President
宣传办公室
电话:(858) 453-4100
press@salk.edu
萨尔克研究所是一个独立的非营利性研究机构,由首个安全有效的脊髓灰质炎疫苗的研发者乔纳斯·索尔克于1960年创立。该研究所的使命是推动以合作、敢于冒险为特点的基础性研究,以应对癌症、阿尔茨海默病和农业脆弱性等社会最紧迫的挑战。这项基础科学支撑着所有的转化研究,产生有助于全球新药和创新的见解。.